GnRH agonists vs antagonists
Tóm tắt
Từ khóa
Tài liệu tham khảo
Loumaye, 1990, The control of endogenous secretion of LH by gonadotrophin-releasing hormone agonists during ovarian hyperstimulation for in-vitro fertilization and embryo transfer, Hum Reprod, 5, 357, 10.1093/oxfordjournals.humrep.a137105
Lejeune, 1986, In vitro fertilization and embryo transfer as related to endogenous luteinizing hormone rise or human chorionic gonadotropin administration, Fertil Steril, 45, 377, 10.1016/S0015-0282(16)49220-4
Porter, 1984, Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins, Lancet, 2, 1284, 10.1016/S0140-6736(84)92840-X
Schally, 1971, Isolation and properties of the FSH and LH-releasing hormone, Biochem Biophys Res Commun, 43, 393, 10.1016/0006-291X(71)90766-2
Fujino, 1974, Some analogs of luteinizing hormone releasing hormone (LH-RH) having intense ovulation-inducing activity, Biochem Biophys Res Commun, 57, 1248, 10.1016/0006-291X(74)90830-4
Clayton, 1980, Receptor-binding affinity of gonadotropin-releasing hormone analogs: analysis by radioligand-receptor assay, Endocrinology, 106, 1154, 10.1210/endo-106-4-1154
Karten, 1986, Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective, Endocr Rev, 7, 44, 10.1210/edrv-7-1-44
Reissmann, 1995, Development and applications of luteinizing hormone-releasing hormone antagonists in the treatment of infertility: an overview, Hum Reprod, 10, 1974, 10.1093/oxfordjournals.humrep.a136219
Kenigsberg, 1984, Medical hypophysectomy: I. Dose-response using a gonadotropin-releasing hormone antagonist, Fertil Steril, 42, 112, 10.1016/S0015-0282(16)47968-9
Klingmuller, 1993, Hormonal responses to the new potent GnRH antagonist Cetrorelix, Acta Endocrinol (Copenh), 128, 15, 10.1530/acta.0.1280015
Hahn, 1985, Reproductive/endocrine and anaphylactoid properties of an LHRH-antagonist, ORF 18260, Life Sci, 37, 505, 10.1016/0024-3205(85)90462-X
Hughes, 1992, The routine use of gonadotropin-releasing hormone agonists prior to in vitro fertilization and gamete intrafallopian transfer: a meta-analysis of randomized controlled trials, Fertil Steril, 58, 888, 10.1016/S0015-0282(16)55430-2
Smitz, 1992, Pituitary gonadotrophin secretory capacity during the luteal phase in superovulation using GnRH-agonists and HMG in a desensitization or flare-up protocol, Hum Reprod, 7, 1225, 10.1093/oxfordjournals.humrep.a137831
Forman, 1990, Severe ovarian hyperstimulation syndrome using agonists of gonadotropin-releasing hormone for in vitro fertilization: a European series and a proposal for prevention, Fertil Steril, 53, 502, 10.1016/S0015-0282(16)53348-2
Daya, 2000, Gonadotropin releasing hormone agonist protocols for pituitary desensitization in in vitro fertilization and gamete intrafallopian transfer cycles, Cochrane Database Syst Rev, 2, CD001299
Ljungqvist, 1988, Antide and related antagonists of luteinizing hormone release with long action and oral activity, Proc Natl Acad Sci USA, 85, 8236, 10.1073/pnas.85.21.8236
Dubourdieu, 1991, Suppression of corpus luteum function by the gonadotropin-releasing hormone antagonist Nal-Glu: effect of the dose and timing of human chorionic gonadotropin administration, Fertil Steril, 56, 440, 10.1016/S0015-0282(16)54537-3
Rabinovici, 1992, Endocrine effects and pharmacokinetic characteristics of a potent new gonadotropin-releasing hormone antagonist (Ganirelix) with minimal histamine-releasing properties: studies in postmenopausal women, J Clin Endocrinol Metab, 75, 1220, 10.1210/jc.75.5.1220
Duijkers, 1998, Single and multiple dose pharmacokinetics and pharmacodynamics of the gonadotrophin-releasing hormone antagonist Cetrorelix in healthy female volunteers, Hum Reprod, 13, 2392, 10.1093/humrep/13.9.2392
Mannaerts, 2000, Embryo implantation and GnRH antagonists: GnRH antagonists do not activate the GnRH receptor, Hum Reprod, 15, 1882, 10.1093/humrep/15.9.1882
Leroy, 1994, A single injection of a gonadotropin-releasing hormone (GnRH) antagonist (Cetrorelix) postpones the luteinizing hormone (LH) surge: further evidence for the role of GnRH during the LH surge, Fertil Steril, 62, 461, 10.1016/S0015-0282(16)56932-5
Diedrich, 1994, Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation, Hum Reprod, 9, 788, 10.1093/oxfordjournals.humrep.a138597
Olivennes, 1994, The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vitro fertilization-embryo transfer program, Fertil Steril, 62, 468, 10.1016/S0015-0282(16)56933-7
Albano, 1997, Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation, Fertil Steril, 67, 917, 10.1016/S0015-0282(97)81407-0
Olivennes, 1998, The use of a GnRH antagonist (Cetrorelix) in a single dose protocol in IVF-embryo transfer: a dose finding study of 3 versus 2mg, Hum Reprod, 13, 2411, 10.1093/humrep/13.9.2411
Fischl, 2001, Obruca a Zeitliche optimierung der kontrollierten hyperstimulation (koh) in kombination mit gnrh-antagonisten und ovulationshemmer in einem ivf-programm, Journal Für Fertilität Und Reproduktion, 11, 50
Kolibianakis, 2006, Effect of oral contraceptive pill pretreatment on ongoing pregnancy rates in patients stimulated with GnRH antagonists and recombinant FSH for IVF. A randomized controlled trial, Hum Reprod, 21, 352, 10.1093/humrep/dei348
Rombauts, 2006, A comparative randomized trial to assess the impact of oral contraceptive pretreatment on follicular growth and hormone profiles in GnRH antagonist-treated patients, Hum Reprod, 21, 95, 10.1093/humrep/dei302
Griesinger, 2004, What is the most relevant standard of success in assisted reproduction? Is BESST (birth emphasizing a successful singleton at term) truly the best?, Hum Reprod, 19, 1239, 10.1093/humrep/deh237
Germond, 2004, What is the most relevant standard of success in assisted reproduction? The cumulated singleton/twin delivery rates per oocyte pick-up: the CUSIDERA and CUTWIDERA, Hum Reprod, 19, 2442, 10.1093/humrep/deh501
Heijnen, 2004, What is the most relevant standard of success in assisted reproduction? The next step to improving outcomes of IVF: consider the whole treatment, Hum Reprod, 19, 1936, 10.1093/humrep/deh368
Min, 2004, What is the most relevant standard of success in assisted reproduction? The singleton, term gestation, live birth rate per cycle initiated: the BESST endpoint for assisted reproduction, Hum Reprod, 19, 3, 10.1093/humrep/deh028
Tiitinen, 2004, What is the most relevant standard of success in assisted reproduction? The value of cryopreservation on cumulative pregnancy rates per single oocyte retrieval should not be forgotten, Hum Reprod, 19, 2439, 10.1093/humrep/deh446
Arce, 2005, Resolving methodological and clinical issues in the design of efficacy trials in assisted reproductive technologies: a mini-review, Hum Reprod, 20, 1757, 10.1093/humrep/deh818
Ludwig, 2001, Use of GnRH antagonists in ovarian stimulation for assisted reproductive technologies compared to the long protocol. Meta-analysis, Arch Gynecol Obstet, 265, 175, 10.1007/s00404-001-0267-2
Al-Inany, 2002, GnRH antagonist in assisted reproduction: a Cochrane review, Hum Reprod, 17, 874, 10.1093/humrep/17.4.874
Daya, 2003, A comparison of clinical pregnancy rates in the efficacy evaluation of GnRH agonist versus antagonist use for assisted reproduction – a meta-analysis using an intention to treat approach, Gynaecol Endocrinol, 17, 44
Kolibianakis EM, Collins J, Tarlatzis BC et al. Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis. Hum Reprod Update [in press].